欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0487/001
药品名称Olmedipin
活性成分
    • amlodipine besilate 5.0 mg
    • olmesartan medoxomil 20.0 mg
剂型Film-coated tablet
上市许可持有人KRKA, d.d., Novo mesto, Slovenia Šmarješka cesta 6 Novo mesto 8501 Slovenia
参考成员国 - 产品名称Hungary (HU)
OLMIZA 20 mg/5 mg filmtabletta
互认成员国 - 产品名称
    • Greece (GR)
    • Cyprus (CY)
      Alsamod 20 mg/5 mg επικαλυμμένα με λεπτό υμένιο δισκία
    • Germany (DE)
      Olmedipin 20 mg/5 mg Filmtabletten
    • Belgium (BE)
      Olmesartan/Amlodipine Krka 20 mg/5 mg filmomhulde tabletten
    • Ireland (IE)
    • Austria (AT)
      Olmesartan/Amlodipin Krka 20 mg/5 mg Filmtabletten
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Finland (FI)
    • Poland (PL)
      Olmita
    • Lithuania (LT)
      Olmira 20 mg / 5 mg plėvele dengtos tabletės
    • Bulgaria (BG)
      Olmita
    • Slovakia (SK)
      Olmita 20 mg/5 mg filmom obalené tablety
    • Slovenia (SI)
      Olmita 20 mg/5 mg filmsko obložene tablete
    • Croatia (HR)
      Olmita 20 mg/5 mg filmom obložene tablete
    • Romania (RO)
      Olssa 20 mg/5 mg comprimate filmate
许可日期2017/07/19
最近更新日期2024/04/26
药物ATC编码
    • C09DB02 olmesartan medoxomil and amlodipine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase